BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37331182)

  • 21. In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
    Younes ST; Herrington B
    PLoS One; 2020; 15(11):e0242521. PubMed ID: 33206716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.
    Balasubramanian A; Gunjur A; Gan HK; Perchyonok Y; Cher LM
    J Clin Neurosci; 2020 Sep; 79():269-271. PubMed ID: 33070910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
    Faulkner C; Ellis HP; Shaw A; Penman C; Palmer A; Wragg C; Greenslade M; Haynes HR; Williams H; Lowis S; White P; Williams M; Capper D; Kurian KM
    J Neuropathol Exp Neurol; 2015 Sep; 74(9):867-72. PubMed ID: 26222501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
    Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
    Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
    Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
    J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas.
    Appay R; Fina F; Macagno N; Padovani L; Colin C; Barets D; Ordioni J; Scavarda D; Giangaspero F; Badiali M; Korshunov A; M Pfister S; T W Jones D; Figarella-Branger D
    Mod Pathol; 2018 Oct; 31(10):1490-1501. PubMed ID: 29802359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
    Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
    PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of the MAPK pathway in pilocytic astrocytomas.
    Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
    Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
    Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
    Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior.
    Bannykh SI; Mirocha J; Nuno M; Lopategui J; Kandala G
    Clin Neuropathol; 2014; 33(6):388-98. PubMed ID: 25066317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
    Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
    J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
    Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
    Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of a pilocytic astrocytoma with histological features of anaplasia and unprecedent genetic alterations.
    Moritsubo M; Furuta T; Negoto T; Nakamura H; Uchiyama Y; Morioka M; Oshima K; Sugita Y
    Neuropathology; 2024 Apr; 44(2):161-166. PubMed ID: 37779355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    Jeuken JW; Wesseling P
    J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between magnetic resonance imaging characteristics and BRAF alteration status in individuals with optic pathway/hypothalamic pilocytic astrocytomas.
    Ishi Y; Yamaguchi S; Yoshida M; Motegi H; Kobayashi H; Terasaka S; Houkin K
    J Neuroradiol; 2021 Jun; 48(4):266-270. PubMed ID: 31228537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.
    Bar EE; Lin A; Tihan T; Burger PC; Eberhart CG
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):878-87. PubMed ID: 18716556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics.
    Salles D; Laviola G; Malinverni ACM; Stávale JN
    J Child Neurol; 2020 Oct; 35(12):852-858. PubMed ID: 32691644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.